NewswireToday - /newswire/ -
Salt Lake City, UT, United States, 2012/09/13 - 32ATPscientific consulting, LLC (32ATPs) announces that effective October 1 our New York corporate office will be relocated to Salt Lake City, Utah and fully operational - 32ATPs.com.
Our new headquarters will continue our deep investment and commitment to providing integrated management solutions to the life science and biotech community. The corporate relocation reflects 32ATPs efforts to expand the company’s presence into western US markets, a central goal in the companies five year initiative. Salt Lake City has been ranked “One of the Fastest Growing Job Markets in the US”, and provides major research and educational assets and high level of state investment in biotech start ups as well as an active healthy lifestyle, beautiful mountainous surroundings, sustainability, culture and more.
“32ATPs presence in the emerging market of scientific project management and relocation to the western United States enables us to leverage our deep knowledge of project management in the life sciences and biotech arenas of one of the most stable biotech growth markets in the US, the “Silicone Slopes” of Salt Lake City.” said Dr. Carol L. Curchoe, President and CEO of 32ATPs. Our goal is to become the Management Consultant partner of choice for biotech and pharma companies nationwide” she added.
32ATPs is growing and we thank our customers for the business you entrust in us.
32ATPScientific consulting, LLC (32atps.com) provides professional scientific consulting services to individuals, biotech, pharmaceutical and academic institutions. We offer a wide range of services aimed at increasing efficiency, decreasing costs, developing broad strategic plans and solving workflow problems.
Forward looking statements
Certain of the statements contained in this news release may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements contained herein relating to 32ATPs products, markets, strategy or operating results, including without limitation its expected operating results, are forward-looking, such statements are based on current expectations and assumptions that involve a number of uncertainties and risks.